Objectives

After participating in this educational activity, attendees should be able to:

1| Explore mechanisms of plaque development and rupture in atherosclerosis​
2| Assess the impact of Percutaneous Coronary Intervention in managing heart disease​
3| Evaluate the potential of P2Y12 inhibitors as a monotherapy post-PCI​
4| Highlight missing aspects and areas for further study in PCI and antithrombotic therapy​
 
Presenter(s): 
Damaris Fuentes, PharmD
PGY1 Community Based Pharmacy Resident
Pharmacist
Baystate Medical Center
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Damaris Fuentes, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
01/27/2025 - 2:00pm to 3:00pm EST
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours

Please login or register to take this course.